Наукова електронна бібліотека
періодичних видань НАН України

Перегляд Experimental Oncology за темою "Reviews"

Репозиторій DSpace/Manakin

Перегляд Experimental Oncology за темою "Reviews"

Сортувати за: Порядок: Результатів:

  • Accelerated cellular senescence in solid tumor therapy 
    Wu, P.C.; Wang, Q.; Grobman, L.; Chu, E.; Wu, D.Y. (Experimental Oncology, 2012)
    Accelerated cellular senescence (ACS) is an emerging concept that implicates sustained, telomere-independent cell cycle arrest of neoplastic cells in response to chemotherapeutic agents, ionizing radiation, oxidative stress, ...
  • Amplification and co-regulators of androgen receptor gene in prostate cancer 
    Golias, Ch.; Iliadis, I.; Peschos, D.; Charalabopoulos, K. (Experimental Oncology, 2009)
    Prostate cancer isthe second most common malignancy among males after lung cancer. The growth of prostate cancer cells depends on the presence of androgens, a group ofsteroid hormones that include testosterone and its ...
  • Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome 
    Grybach, S.M.; Polishchuk, L.Z.; Chekhun, V.F. (Experimental Oncology, 2018)
    Aim: To analyze the survival of patients with breast cancer (BC) depending on age, molecular subtype of the tumor and the presence of metabolic syndrome. Patients and Methods: We have analyzed the results of examination ...
  • Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome 
    Grybach, S.M.; Polishchuk, L.Z.; Chekhun, V.F. (Experimental Oncology, 2018)
    Aim: To analyze the survival of patients with breast cancer (BC) depending on age, molecular subtype of the tumor and the presence of metabolic syndrome. Patients and Methods: We have analyzed the results of examination ...
  • An overview on "cellular cannibalism” with special reference to oral squamous cell carcinoma 
    Jain, M. (Experimental Oncology, 2015)
    Cellular cannibalism has been defined as a large cell engulfing a slightly smaller one within its cytoplasm. It has been described in various cancers like bladder cancer, breast cancer, lung cancer, gastric cancer, oral ...
  • Anticancer substances of mushroom origin 
    Ivanova, T.S.; Krupodorova, T.A.; Barshteyn, V.Y.; Artamonova, A.B.; Shlyakhovenko, V.A. (Experimental Oncology, 2014)
    The present status of investigations about the anticancer activity which is inherent to medicinal mushrooms, as well as their biomedical potential and future prospects are discussed. Mushroom products and extracts possess ...
  • Anticancer therapy and apoptosis imaging 
    Yalcin, T.J.; Haimovitz-Friedman, A.; Verheij, M. (Experimental Oncology, 2012)
    Early response prediction is considered an essential tool to obtain a more customized anticancer treatment because it allows for the identification of patients who will benefit most from a particular therapy and prevents ...
  • Apoptosis in radiation therapy: a double-edged sword 
    Balcer-Kubiczek, E.K. (Experimental Oncology, 2012)
    Radiation therapy achieves its therapeutic effects by inducing apoptosis and non-apoptotic cell death. The aim of this focused review is to highlight the aspects of the cell death pathways most relevant to conventional ...
  • At a crossroads of cancer risk and aging: the role of telomeres 
    Gerashchenko, B.I. (Experimental Oncology, 2010)
    The risk of overall cancer inevitably increases with advancing age. The cancer incidence rate is not constant within the human life span (it exponentially increases with advancing age). Aging itself is a complex biological ...
  • Carbon adsorbents in oncology: achievements and perspectives 
    Nikolaev, V.G.; Sakhno, L.A.; Snezhkova, E.A.; Sarnatskaya, V.V.; Yushko, L.A. (Experimental Oncology, 2011)
    The results of own investigations and literature data are summarized to determine the place of the main methods of adsorption therapy in complex treatment of the patients with malignant tumors. New possibilities for the ...
  • Caspase-8 regulation of TRAIL-mediated cell death 
    Crowder, R.N.; El-Deiry, W.S. (Experimental Oncology, 2012)
    Research on TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors has advanced tremendously over the past 17 years. Initial observations of TRAIL and TRAIL receptor-mediated tumor cell toxicity led to enthusiasm ...
  • Caspase Control: Protagonists of Cancer Cell Apoptosis 
    Fiandalo, M.V.; Kyprianou, N. (Experimental Oncology, 2012)
    Emergence of castration-resistant metastatic prostate cancer is due to activation of survival pathways, including apoptosis suppression and anoikis resistance, and increased neovascularization. Thus targeting of apoptotic ...
  • c-FLIP, a master anti-apoptotic regulator 
    Safa, A.R. (Experimental Oncology, 2012)
    Cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein (c-FLIP) is a master anti-apoptotic regulator and resistance factor that suppresses tumor necrosis factor-α (TNF-α), Fas-L, and TNF-related apoptosis-inducing ...
  • Characterization of breast cancer DNA content profiles as a prognostic tool 
    Gerashchenko, B.I.; Huna, A.; Erenpreisa, J. (Experimental Oncology, 2014)
    Worldwide, breast cancer in women remains to be the most common malignancy that in a considerable proportion shows the resistance to genotoxic treatments and poor outcome. Chromosomal instability manifested as aneuploidy ...
  • Chornobyl catastrophe: cytogenetic effects of low dose ionizing radiation and their modification 
    Domina, E.A. (Experimental Oncology, 2016)
    Among the long-term effects of the Chornobyl disaster the greatest concern of international medical and scientific community is given to the established fact of excess of the spontaneous level of cancer incidence in the ...
  • Chronic periodontitis and the risk of head and neck squamous cell carcinoma: facts and figures 
    Gondivkar, S.M.; Gondivkar, R.S.; Gadbail, A.R.; Chole, R.; Mankar, M.; Yuwanati, M. (Experimental Oncology, 2013)
    Substantial evidence supports an association between periodontal disease and several systemic diseases including cardiovascular diseases, diabetes mellitus, respiratory diseases, adverse pregnancy outcomes, osteoporosis ...
  • Chronic periodontitis and the risk of head and neck squamous cell carcinoma: facts and figures 
    Gondivkar, S.M.; Gondivkar, R.S.; Gadbail, A.R.; Chole R.; Mankar M.; Yuwanati M. (Experimental Oncology, 2013)
    Substantial evidence supports an association between periodontal disease and several systemic diseases including cardiovascular diseases, diabetes mellitus, respiratory diseases, adverse pregnancy outcomes, osteoporosis ...
  • Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects 
    Cherdyntseva, N.V.; Litviakov, N.V.; Denisov, E.V.; Gervas, P.A.; Cherdyntsev, E.S. (Experimental Oncology, 2017)
    Each patient has a unique history of cancer ecosystem development, resulting in intratumor heterogeneity. In order to effectively kill the tumor cells by chemotherapy, dynamic monitoring of driver molecular alterations is ...
  • Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release 
    Monian, P.; Jiang, X. (Experimental Oncology, 2012)
    In mammalian cells, the mitochondrial pathway of apoptosis plays a key role in various biological processes and has been extensively studied. One of the signature features of this pathway is permeabilization of the outer ...
  • Clinical implications of p53 alterations in oral cancer progression: a review from India 
    Patel, K.R.; Vajaria, B.N.; Singh, R.D.; Begum, R.; Patel, P.S. (Experimental Oncology, 2018)
    p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause ...

Пошук


Розширений пошук

Перегляд

Мій обліковий запис